BioSpace News Archive

Galderma announces significant investments across its aesthetic portfolio including digital enhancements to ASPIRE Galderma Rewards and an expansion of its U.S. salesforce. Additionally, Galderma has launched a collaboration with premium skincare brand ZO® Skin Health

Organizations collaborate for National Kidney Month to raise awareness about the deadly disease

DiscGenics, Inc. , a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has completed enrollment in its Phase 1/2 first-in-human U.S. clinical study of IDCT

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced publication of results from a survey of patients with refractory Mycobacterium avium complex (MAC) lung disease on the clinical management of respiratory adverse events (AEs) associated with ARIKAYCE® (amikacin liposome inhalation suspension) treatment

HealthVerity, the trusted technology partner to the life sciences and insurance industries, announced today the expansion of its healthcare data ecosystem to include the most comprehensive set of closed pharmacy and medical payer data available in the market

Caregility, a clinical collaboration and communications company focused on providing secure, reliable two-way audio and video communications in both inpatient and outpatient settings, announces the appointment of Major General Elder Granger, USA, Ret., to the Caregility Advisory Board.

Merck (NYSE: MRK), known as MSD outside the United States and Canada launches a new public awareness campaign about cancer immunotherapy, a type of cancer treatment that uses the body’s own immune system to fight cancer.

Vivify Health, the developer of the nation’s leading connected care platform for holistic patient care and engagement, today announced the availability of its new dashboards with reporting capabilities.

The Virginia Center for Addiction Medicine, a premier outpatient addiction treatment center, announced today that it has appointed Dr. Andreas Bienert as its clinical program director.

Motus GI Holdings, Inc. , (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and year ended December 31, 2019 financial results on Monday, March 30, 2020